# Precisio Biotix

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/precisio-biotix
Canonical HTML page: https://getyourbrief.com/entity/precisio-biotix

## Recent coverage (2 stories, network-wide)

### Lysin Therapies Target 1.27M Annual AMR Deaths: Apollo & Precisio Biotix Partner
2026-07-23 03:40:17 · Sector: bio · Sentiment: Positive · Impact: 8/10 · Sources: 2

In a bid to develop precision antimicrobials, Apollo Hospitals and Precisio Biotix are advancing lysin-based therapies in India, a country with one of the highest AMR burdens. The collaboration will include compassionate use clinical programs, potentially accelerating regulatory pathways for this new drug class.
Full story: https://getbiobrief.com/story/apollo-precisio-biotix-lysin-amr-bio

### Apollo Hospitals Targets India's 297K Annual AMR Deaths with Lysin Therapy
2026-07-23 03:38:42 · Sector: health · Sentiment: Positive · Impact: 8/10 · Sources: 2

Apollo Hospitals partners with Precisio Biotix to introduce next-generation lysin therapies in India, directly addressing the country's 297,000 annual deaths from antimicrobial resistance. The collaboration will leverage Apollo's vast hospital network for clinical validation and compassionate use programs, potentially transforming hospital infection control and patient outcomes.
Full story: https://gethealthbrief.com/story/apollo-hospitals-lysin-amr-india-health

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.